GRAIL Inc (GRAL)

Form 4 - Statement of changes in beneficial ownership of securities

Form 4 - Statement of changes in beneficial ownership of securities

Form 144 - Report of proposed sale of securities

Form 3 - Initial statement of beneficial ownership of securities

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially Increased Cancer Detection With Robust Performance and Favorable Safety at 2026 ASCO Annual Meeting

GRAIL Presents PATHFINDER 2 Results of More Than 35,000 Participants Showing the Galleri® Test Substantially...

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer Diagnoses at 2026 ASCO Annual Meeting

GRAIL Reports Full Results From NHS-Galleri Trial Demonstrating Substantial Reduction in Stage IV Cancer...

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

GRAIL Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) PR Newswire MENLO PARK, Calif., May...

GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference

GRAIL to Present at the Goldman Sachs 47th Annual Global Healthcare Conference PR Newswire MENLO PARK...

GRAIL to Present at the 2026 Jefferies Global Healthcare Conference

GRAIL to Present at the 2026 Jefferies Global Healthcare Conference PR Newswire MENLO PARK, Calif., May 21...

Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Form 8-K - Current report

GRAIL Reports First Quarter 2026 Financial Results

GRAIL Reports First Quarter 2026 Financial Results PR Newswire MENLO PARK, Calif., May 5, 2026 Q1...

GRAIL to Present at the BofA Securities 2026 Health Care Conference

GRAIL to Present at the BofA Securities 2026 Health Care Conference PR Newswire MENLO PARK, Calif., April...

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material